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Commensal microbes can have a substantial impact
on autoimmune disorders, but the underlying molec-
ular and cellular mechanisms remain largely unex-
plored. We report that autoimmune arthritis was
strongly attenuated in the K/BxNmousemodel under
germ-free (GF) conditions, accompanied by reduc-
tions in serum autoantibody titers, splenic autoanti-
body-secreting cells, germinal centers, and the
splenic T helper 17 (Th17) cell population. Neutraliza-
tion of interleukin-17 prevented arthritis develop-
ment in specific-pathogen-free K/BxNmice resulting
from a direct effect of this cytokine on B cells to
inhibit germinal center formation. The systemic defi-
ciencies of the GF animals reflected a loss of Th17
cells from the small intestinal lamina propria. Intro-
duction of a single gut-residing species, segmented
filamentous bacteria, into GF animals reinstated the
lamina propria Th17 cell compartment and produc-
tion of autoantibodies, and arthritis rapidly ensued.
Thus, a single commensal microbe, via its ability to
promote a specific Th cell subset, can drive an auto-
immune disease.
INTRODUCTION
Mammals host trillions of microbes at diverse locations
throughout the body, in particular in the gut (Ba¨ckhed et al.,
2005; Ley et al., 2006, 2008b). The enormity and complexity of
these commensal (or mutualistic) communities have been
difficult to deal with until recently, when striking advances in
‘‘next generation’’ sequencing methods, entailing either 16S
rRNA or ‘‘shotgun’’ cataloguing, rendered this field navigable
terrain.
The gut microbiomes of humans and mice are broadly similar
(Ba¨ckhed et al., 2005; Ley et al., 2006, 2008a, 2008b). In both
cases,1000 different microbial species from10 different divi-sions colonize the gastrointestinal tract, but just two bacterial
divisions—the Bacteroidetes and Firmicutes—and one member
of the Archaea appear to dominate, together accounting for
98% of the 16S rRNA sequences obtained from this site. The
number and identity of microbial communities vary along the
length of the gut, in a proximal to distal gradient of abundance
(small intestine < cecum < colon) and across the three dimen-
sions of the lumen and mucous layers. The total number of genes
borne by the gastrointestinal microbiome has been estimated to
exceed more than a 100-fold that of the human genome (Ley
et al., 2006). The products of these genes are put to good use
by the host, for example in digestion, production of nutrients,
detoxification, defense against pathogens, and development of
a competent immune system (Ba¨ckhed et al., 2005; Ley et al.,
2006, 2008b).
The gastrointestinal microbiome and the immune system are
closely tied, each influencing and being influenced by the other
(Macpherson and Harris, 2004; Mazmanian and Kasper, 2006;
Rakoff-Nahoum and Medzhitov, 2008; Vassallo and Walker,
2008; Duerkop et al., 2009). In general terms, the incomplete
state of the immune system in germ-free (GF) conditions and in
neonatal individuals argues that its normal maturation is driven
by commensal microbes—for example, GF-housed individuals
and neonates can have a reduced fraction of peripheral CD4+
T lymphocytes, a systemic tilt toward the T helper 2 (Th2) cell
phenotype, defective T and B cell compartments in gut-associ-
ated lymphoid tissue, reduced complements of immunoglobulin
G (IgG) and IgA antibodies (Abs), etc. (Mazmanian et al., 2005,
2008; Rakoff-Nahoum et al., 2004; Ivanov et al., 2008; Atarashi
et al., 2008; Grice et al., 2009; Macpherson and Harris, 2004;
Vassallo and Walker, 2008). In more specific terms, gut-resident
bacteria—sometimes even a single species—can have a strong
influence on the emergence and/or maintenance of particular
CD4+ T cell subsets. Examples include the effects of specific
bacteria on the emergence of Th17 cells in the intestinal lamina
propria (LP) (Ivanov et al., 2008, 2009; Atarashi et al., 2008; Salz-
man et al., 2010; Gaboriau-Routhiau et al., 2009) and the impact
ofBacteroides fragilis on systemic Th1 cells and local interleukin-
10 (IL-10)-producing regulatory T cells (Mazmanian et al., 2005,
2008). In both cases, dendritic cells (DCs) are thought to be the
initial target of mediators produced either by the culprit microbeImmunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc. 815
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Figure 1. Attenuation of Arthritis in GF K/xBN Mice
(A and B) Ankle thickening values (A) and anti-GPI titers (B) for GF and SPF
K/BxN mice of the indicated ages. Each symbol represents one animal; bars
indicate the group mean.
(C) GF K/BxN mice were shipped to our SPF facility and upon weaning
(day 21), ankle thickening was measured from day 23. Closed circles, average
of ankle thickening ± SEM, serially measured on cohorts; closed triangles,
analogous measurements for SPF-housed K/BxN mice; open circles, values
for individual GF-housed K/BxN mice, not measured serially because of exper-
imental contingencies.
(D) Sera were collected at the end of the experiment depicted in (C). The bar
indicates the mean.
Asterisks indicate statistical significance via the Student’s t test (*p = 0.05,
**p < 0.05, ***p < 0.005).
Immunity
The Gut Microbe SFB Can Trigger Arthritisor in response to it—adenosine-50-triphosphate (ATP) or serum
amyloid A (SAA) in the former case (Atarashi et al., 2008; Ivanov
et al., 2009) and the polysaccharide PSA in the latter (Mazmanian
et al., 2005).
Given these tight associations, it is not surprising that gut
microbiota have been linked to pathologies of the immune
system, notably allergies and autoimmune disorders (Strachan,
1989; Wills-Karp et al., 2001; Kelly et al., 2007). Ties to inflamma-
tory bowel diseases are easy to understand, but the cellular and
molecular mechanisms by which intestinal commensals influ-
ence autoimmune responses at distal sites remain enigmatic.
The time seems ripe to apply new, and rapidly emerging, knowl-
edge about the composition and properties of the gastrointes-
tinal microbiome and about the activities of recently discovered
effector and regulatory T cell subsets to dissecting these
mechanisms in autoimmune disease models. We chose to study
the K/BxN T cell receptor (TCR) transgenic mouse model of
inflammatory arthritis because of its easily distinguishable initia-
tion and effector stages (Kouskoff et al., 1996; Korganow et al.,
1999; Matsumoto et al., 1999). The initiation phase relies
primarily on the adaptive immune system. T lymphocytes dis-
playing the transgene-encoded TCR recognize a self-peptide
derived from glucose-6-phosphate isomerase (GPI) presented
by the major histocompatibility complex class II molecule, Ag7;
these autoreactive T cells provide exceptionally effective help
to GPI-specific B cells, resulting in massive production of GPI
autoAbs, primarily of the IgG1 isotype. The effector phase, which
can be mimicked by transfer of serum from K/BxN into standard
mice, is executed primarily by innate immune system players.
GPI:anti-GPI immune complexes initiate a self-sustaining inflam-
matory response that mobilizes mast cells, neutrophils, the alter-
native pathway of complement, Fcg receptors, tumor necrosis
factor-a (TNF-a), IL-1, etc. Arthritis ensues rapidly (beginning at
about 4 weeks of age) and with high penetrance (close to 100%).
Here we report that arthritis was attenuated in K/BxN mice
housed under GF conditions. Disease dampening was traced
to a dearth of Th17 cells, which could be reversed by introducing
segmented filamentous bacteria (SFB) into the gut of GF-housed
mice, provoking rapid onset of arthritis. Thus, we provide an
example of an extra-gut autoimmune disease triggered by
a single member of the commensal intestinal microbiota through
its promotion of a particular Th cell subset.
RESULTS
Germ-Free K/BxN Mice Have Reduced GPI AutoAb
Titers and Attenuated Arthritis
To explore the impact of commensal microbes on the develop-
ment of autoimmune arthritis, we established GF colonies of
KRN/B6 and NOD mice and mated the two strains to obtain
K/BxN experimental animals. As judged by both ankle thickening
(Figure 1A) and clinical index (not shown), GF-housed K/BxN mice
developed an attenuated arthritis compared with that of K/BxN
animals contemporaneously housed in a specific-pathogen-free
(SPF) facility—both delayed in onset and reduced in severity.
A key disease landmark in this arthritis model is the production
of high titers of serum GPI autoAbs, which separates the initia-
tion phase, dependent on the adaptive immune system, from
the effector phase, mostly driven by innate immune system816 Immunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc.
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The Gut Microbe SFB Can Trigger Arthritisplayers (Korganow et al., 1999). At 8 weeks of age, serum total
IgG (Figure 1B) as well as IgG1 (Figure S1 available online), the
dominant anti-GPI Ab isotype in the K/BxN model (Korganow
et al., 1999), were substantially lower in GF K/BxN mice than in
their SPF counterparts. At later time points, the difference in
anti-GPI titers under the two housing conditions was not so
apparent, in contrast to the continued attenuation of ankle thick-
ness in GF mice. Such discordance between autoAb titers and
the degree of ankle thickening is frequent at late time points in
this model. At this stage of disease, ankle thickness reflects
primarily bone remodeling and fibrosis, and so is a cumulative
index of disease duration and severity rather than an indicator
of concomitant inflammation (Kouskoff et al., 1996).
To confirm that the differences in disease parameters really
reflected the GF environment—and not, for example, genetic
drift—and to evaluate their reversibility, we transferred 21-day-
old GF K/BxN mice back into our SPF facility. After 14 days,
they had already begun to develop arthritis, which soon sur-
passed the disease of straight GF K/BxN animals in both its
speed and severity but was still delayed and diminished vis-a`-
vis straight SPF counterparts (Figure 1C). Clinical disease
severity reflected the titers of GPI autoAb attained at 7 weeks
of age under the three housing conditions (Figure 1D). Thus,
commensal microbes are required for the development of high
GPI autoAb titers and severe arthritis in the K/BxN model.
The Impact of Commensal Microbes on the Adaptive
Immune System of K/BxN Mice
Although influences on effector-phase processes certainly
remain possible, the reduced GPI autoAb titers in the absence
of commensal microbes suffices, in and of itself, to explain the
attenuated arthritis in GF K/BxN mice (Matsumoto et al., 1999).
Therefore, we examined the impact of commensals on the adap-
tive immune system in this model, focusing on the spleen
because by far most GPI Ab-secreting cells (ASCs) reside in
this organ (Maccioni et al., 2002; Huang et al., 2010). First, we
surveyed the B lymphocyte compartments, performing a four-
way comparison of splenocytes from 6- to 8-week-old BxN
versus K/BxN mice housed in SPF versus GF conditions. The
percentages and numbers of splenic B cells (CD19+) in GF and
SPF K/BxN mice were similar (Figure S2A), as were, more specif-
ically, their T1 (IgMhiIgDlo), T2 (IgMhiIgDhi), mature (IgMloIgDhi),
follicular (CD21loCD23hi), and marginal zone (CD21hiCD23lo) B
cell compartments (Figures S2B and S2C). SPF K/BxN mice
showed an increase in the percentage of splenic germinal center
(GC) B cells (Fas+PNA-receptor+) vis-a`-vis BxN controls, reflect-
ing activation and expansion of the anti-GPI specificities
(Figure 2A, top). This augmentation did not occur under GF
conditions (Figure 2A, bottom). Perhaps not surprisingly, then,
GF K/BxN mice had a reduced complement of CXCR5+PD1+ T
follicular helper (Tfh) cells, which reside primarily in GCs
(Figure 2B). The spleens of GF K/BxN mice also had a smaller
fraction of anti-GPI ASCs, as measured by an ELISPOT assay
(Figure 2C). These deficiencies can explain the reduced titer of
serum GPI autoAbs in GF K/BxN mice.
Given the established T cell dependence of the GPI autoAb
response (Kouskoff et al., 1996; Korganow et al., 1999), we
also compared the T cell compartments of K/BxN mice kept
under the two husbandry conditions. There were only minorchanges in the representation of thymic or splenic CD4+ or
CD8+ T cells in GF animals, the biggest difference being a
20%–50% reduction in the splenic CD4+ T cell compartment
compared with that of SPF mice (Figures S2D and S2E), and
the activation state of peripheral cells was similar under the
two housing conditions (e.g., Figure 2D). Also, there was no
evident change in either the fraction of CD4+Foxp3+ T regulatory
(Treg) cells or in their in vitro suppressive activity (Figures S2F
and S2G). However, splenocytes from GF K/BxN mice re-
sponded less well than those from SPF K/BxN animals when
challenged in vitro with the relevant GPI peptide at all doses
tested (Figure 2E). Thus, given the particular B and T cell defects
observed, the T helper capabilities of GF K/BxN mice appear to
be somehow compromised.
GF K/BxN Mice Have a Dearth of Splenic
IL-17-Producing T Cells
To permit a broad, unbiased comparison of Th cells from mice
under the two conditions, we performed microarray-based
gene-expression profiling on CD4+ T cells purified from spleens
of SPF and GF BxN and K/BxN animals. A FoldChange/Fold-
Change (FC/FC) plot revealed upregulation of a large number
of transcripts in the K/BxN (versus BxN) T cells; the off-diagonal
disposition of the major cloud of dots indicated that induction
was muted in GF (versus SPF) mice (Figure 3A). Another instruc-
tive manner to compare gene expression in SPF and GF mice is
the ‘‘volcano plots’’ depicted in Figure 3B, which display for each
gene the SPF versus GF FC on the x axis and the p value of this
FC on the y axis. Superimposing previously determined Th cell
signatures (Nurieva et al., 2008) onto the plots showed there to
be minimal changes in GF CD4+ T cells in transcripts typical of
Th2 cells, i.e., no bias to either side of the midline. However, as
indicated by their skewed disposition away from the right, the
Th1 and Th17 cell signatures were both diminished in GF CD4+
T cells. We did not further pursue the defect in the Th1 cell subset
in this study because crossing a null mutation of the gene encod-
ing interferon-g (IFN-g), the major Th1 cell cytokine, into the
K/BxN model had no impact on the arthritis parameters exam-
ined, including ankle thickening, clinical score, and histopa-
thology (Figure S3 and data not shown).
The transcript profiling pointed to a defect in GF K/BxN Th17
cells that encompassed several of this subset’s hallmark
proteins: e.g., reductions in RORgt (1/1.8), IL-17A (1/1.3), IL-21
(1/1.3), IL-22 (1/3.2), and CCR6 (1/1.3) The dearth of IL-17A
was confirmed by both PCR quantification of splenic CD4+
T cell transcripts (Figure 3C) and cytofluorimetric evaluation of
IL-17 amounts in this population restimulated ex vivo (Figure 3D).
According to both assays, Il17a gene expression was strongly
induced in SPF K/BxN vis-a`-vis BxN mice, but this induction
was minimal under GF conditions.
To assess the disease relevance of a defect in the Th17 cell
compartment of K/BxN mice, we performed neutralization
experiments via an IL-17 monoclonal Ab (mAb). Treatment of
25-day-old SPF-housed K/BxN mice, just at arthritis onset,
with anti-IL-17 completely blocked disease progression, which
was reflected in low serum GPI autoAb titers (Figure 4A). In addi-
tion, when GF mice were transferred to the SPF facility, they did
not succumb to arthritis if anti-IL-17 mAb was administered from
the time of transfer (Figure 4B).Immunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc. 817
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Figure 2. Impact of Commensal Flora on the B and T Cell Compartments of K/BxN Mice
(A) Splenocytes from GF or SPF BxN or K/BxN mice were stained with Abs recognizing B220, CD4, or FAS or with PNA-R and were analyzed by flow cytometry,
gating as indicated. Values indicate the percentages of Fas+PNA-R+ cells in total B cells. Data are representative of two independent experiments.
(B) Splenocytes from GF or SPF BxN or K/BxN mice were stained with mAbs recognizing B220, CD4, CXCR5, and PD-1 and were analyzed by flow cytometry,
gating as indicated. Values indicate the percentages of CXCR5+PD-1+ cells in total CD4+ T cells. Data are representative of two independent experiments.
(C) Purified B cells of GF or SPF BxN or K/BxN mice were stimulated with GPI protein (10 mg/ml) for 6 hr. An ELISPOT assay revealed GPI-specific ASCs. Fraction
of GPI-specific ASCs among total B cells; mean + SEM from two independent experiments.
(D) Splenocytes were isolated from SPF or GF K/BxN mice, stained, and analyzed by flow cytometry. The values indicate percentages of CD44+ cells in CD4+
T cells. Data are representative of two independent experiments (SPF BxN, 23.3 ± 0.9 SEM [n = 2]; SPF K/BxN, 61.8 ± 4.8 SEM [n = 3]; GF BxN, 22.1 ± 4.5 SEM
[n = 2]; GF K/BxN, 61.3 ± 3.2 SEM [n = 4]).
(E) Splenocytes were isolated from SPF and GF K/BxN mice and stimulated with GPI282-294 peptide at the indicated concentration.
Data are representative of two independent experiments. Asterisks indicate statistical significance via the Student’s t test, *p < 0.05.
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The Gut Microbe SFB Can Trigger ArthritisBecause IL-17 has generally been thought of as a proinflam-
matory cytokine, its effect on anti-GPI titers may appear
surprising on first consideration. However, Hsu et al. recently
reported a direct impact of IL-17 on GC formation in the BXD2
mouse strain (Hsu et al., 2008). Indeed, anti-IL-17 blocking
studies demonstrated this cytokine to be required for efficient
GC formation in the K/BxN model (Figure 4C). In addition, trans-
fer experiments showed that IL-17’s promotion of GCs was
a direct effect on B cells. 1 3 107 B cells not expressing or
expressing IL-17R were purified from spleens of IL-17R-deficient
or IL-17R-sufficient B6.H-2g7 (B6g7) littermates; each population
was combined with an equal number of splenocytes from
arthritic K/BxN mice; each mix was transferred into lightly irradi-
ated (450R) BxN.Rag1/ recipients; and the recipients’ spleno-
cytes were analyzed 2 weeks later by flow cytometry. B cells
lacking IL-17R could repopulate the spleen (Figure 4D, top) but
showed a substantially diminished capacity to partake in GCs
(Figure 4D, bottom). Thus, a paucity of splenic Th17 cells was
a critical factor in the diminished arthritis of K/BxN mice; IL-17
promoted GPI autoAb production, enhancing GC formation via
a direct effect on B cells.818 Immunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc.Linking Arthritis to Gut Commensals
How can commensal microbes impact on the production of
IL-17 by splenic T cells? Microbial colonization of the gut pro-
motes Th17 cell differentiation in the small-intestinal lamina-
propria (SI-LP), the major site of this subset’s differentiation
(Ivanov et al., 2008; Atarashi et al., 2008). Indeed, Th17 cells
were essentially absent from that site in GF K/BxN animals
(Figure 5A). (In contrast, IL-17-expressing SI-LP CCR6+ gd
T cells were not reduced in K/BxN GF mice—data not shown.)
Several experiments were performed to explore a potential link
between SI-LP and splenic Th17 cells. First, we compared their
appearance through ontogeny: SI-LP Th17 cells arise abruptly
between day 16 and day 25 after birth, around the time of wean-
ing (Ivanov et al., 2008), which is just before the window of
arthritis development previously reported for the K/BxN model,
i.e., days 25–31 (Kouskoff et al., 1996). A direct temporal
comparison of the relevant parameters in SPF K/BxN mice
revealed that SI-LP Th17 cells appeared in substantial numbers
between 2 and 3 weeks of age (Figure 5B), followed closely by
splenic Th17 cells between 3 and 4 weeks (Figure 5B) and
arthritis onset at around 4 weeks (Figure 5B). Second, we looked
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Figure 3. A Defective Th17 Cell Signature in
GF K/BxN Mice
(A) FC (fold change) versus FC plot comparing
gene-expression values of SPF K/BxN versus
BxN mice (x axis) and GF K/BxN versus BxN
mice (y axis). Gene-expression values of each
group were the average values of three chips
from three independent experiments.
(B) Th cell signatures. Th2, Th1, and Th17 cell
signatures were generated from published data
sets (Nurieva et al., 2008), with 2 as the cut-off
for FC over the expression value of two other cell
types. The volcano plots depict the FC for SPF
versus GF K/BxN CD4+ T cells versus the p value
of the FC. Signature genes are superimposed in
red. Values refer to the number of genes upregu-
lated (right) or downregulated (left) in GF vis-a`-vis
SPF T cells. p values from a c2 test are indicated.
(C) IL-4, IFN-g, and IL-17 transcripts in splenic
CD4+ T cells for GF or SPF of B/N or K/BxN mice
were quantified by RT-PCR. The level in SPF
BxN mice was set as 1. Mean + SEM. Results were
compiled from three independent experiments
with two mice per group. p = 0.01 for trans-
criptional fold-induction of IL-17 (SPF versus GF
K/BxN).
(D) Splenocytes of GF or SPF BxN or K/BxN mice
were stained with Abs recognizing CCR6 and IL-17
and were analyzed by flow cytometry. Values
represent percentages of IL-17+CCR6+ cells in
CD3+CD4+B220 cells. Data are representative
of two independent experiments.
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The Gut Microbe SFB Can Trigger Arthritisfor the gut homing receptor, a4b7, on splenic Th17 cells. Sup-
porting an intestinal origin, 30%–50% of splenic Th17 cells
from 5-week-old K/BxN, but not BxN, mice expressed this
receptor, imprinted by intestinal-mucosa-associated DCs (Fig-
ure 5C; Sigmundsdottir and Butcher, 2008). Last, we compared
the sensitivities of the SI-LP and splenic Th17 cell compartments
and of arthritis development to antibiotic treatments. The differ-
entiation of SI-LP Th17 cells in B6 mice is blocked by ampicillin
and vancomycin but not by metronidazole and neomycin, the
latter two targeting anaerobes and Gram-negative bacteria,
respectively, i.e., >90% of gut microbiota (Ivanov et al., 2008).
This pattern of sensitivity was also true of SI-LP and splenic
Th17 cells in K/BxN mice (Figures 6A and 6B), including those
splenic Th17 cells that expressed a4b7 (e.g., Figure 6C). Most
important, treatment of K/BxN mice from birth with vancomycin
or ampicillin, but not metronidazole or neomycin, strongly in-
hibited the development of arthritis (Figure 6D). Interestingly,Immunity 32, 815–8disease was actually exacerbated in the
neomycin-treated animals, suggesting
an additional negative influence of
Gram-negative gut bacteria.
Monocolonization with SFB
Triggers Arthritis in GF K/BxN Mice
It was recently reported that a single
bacterial species that is a component of
normal gut microbiota, SFB was sufficientto induce the development of SI-LP Th17 cells in mice taken from
an SPF facility at the Jackson Laboratory, wherein they typically
show a dearth of both this bacterium and Th17 cells (Ivanov
et al., 2009). This result drew our attention because we had noted
lower GPI autoAb titers and attenuated arthritis development
when first introducing the K/BxN model into Jackson, vis-a`-vis
our SPF colonies in Strasbourg and Boston (data not shown).
Therefore, we tested whether SFB might be arthritogenic by
introducing it, via oral gavage of fecal material from SFB-mono-
colonized mice (versus feces from control mice), into GF K/BxN
mice transferred into an SPF facility at 21 days of age (Figure 7A).
Prior experiments like those illustrated in Figure 1C had demon-
strated that transferred GF mice do develop arthritis, but typi-
cally not until 2 weeks after exposure to SPF conditions, i.e., after
35 days of age. Introduction of SFB greatly accelerated arthritis
onset in the transferred mice, beginning 3 days after gavage, i.e.,
after only 28 days of age (Figure 7B). PCR analysis of fecal27, June 25, 2010 ª2010 Elsevier Inc. 819
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Figure 4. Reduction of Arthritis by Neutralization of IL-17
(A) 25-day-old SPF K/BxN mice were treated with 100 mg of anti-IL-17 or control rat IgG every 3 days, and ankle thickening was measured over time (left). Mean ±
SEM of the two groups (n = 5 in both groups from two independent experiments is plotted; asterisks indicate statistical significance via the Student’s t test,
*p < 0.05). Sera were collected at the end of the experiment, and anti-GPI titers were quantified (right). Symbols represent individual mice; bar indicates the mean.
(B) At 23 days of age, GF mice were transferred to our SPF facility and were treated with 100 mg anti-IL-17 or control rat IgG every 3 days from day 24. Otherwise
as in (A) (n = 4 in both groups from one experiment; asterisks indicate statistical significance via the Student’s t test, *p < 0.05).
(C) SPF K/BxN mice were treated as in (A). At the end of treatment, splenocytes were isolated and stained with Abs recognizing B220, CD4, or Fas, or with PNA,
and were analyzed by flow cytometry, gating as indicated. Values represent the percentages of Fas+PNA-R+ cells in total B cells. Data are representative of two
independent experiments with two mice per group.
(D) B cells from either WT or Il17ra/ mice were combined with splenocytes from arthritic K/BxN mice and transferred into BxN.Rag1/ recipients. The origins
of B cells were identified by expression of the congenic marker: CD45.1+CD45.2+ for K/BxN B cells and CD45.2 for Il17ra/ or WT B cells. Percentages of K/BxN
B cells and Il17ra/ or WT B cells among total B cell or GC B cell populations are indicated. The quantitative data of Il17ra/ or WT B cell percentage among
total B cells and GC B cells were also shown as mean + SEM (n = 4, data combined from two independent experiments).
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The Gut Microbe SFB Can Trigger Arthritismaterial at 6 days after gavage indicated that at this early time
point only those mice administered SFB-containing feces were
colonized with SFB (Figure 7C). Flow cytometry of SI-LP and
spleen cells at 33 days of age confirmed the association between
SFB colonization, the appearance of Th17 cells in SI-LP, their
migration to the spleen (Figures 7D and 7E), and the triggering
of arthritis (Figure 7B). As anticipated, introduction of SFB led
to an elevation of GPI autoAb titers to amounts that are known
to induce arthritis (Figure 7F; cf. Figure 1B). Thus, a single bacte-
rial species, SFB, is capable of triggering arthritis development in
K/BxN mice through promotion of Th17 cell populations in the
SI-LP and spleen, leading to high titers of circulating GPI
autoAbs, the critical disease driver in this model.
DISCUSSION
Recent studies have highlighted a critical role for gut microbiota
(Niess et al., 2008; Atarashi et al., 2008; Ivanov et al., 2008), in820 Immunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc.particular SFB (Salzman et al., 2010; Gaboriau-Routhiau et al.,
2009; Ivanov et al., 2009), in the differentiation of Th17 cells in
the intestinal LP. The data presented herein establish the rele-
vance of these observations for the initiation of autoimmune
disease—in particular, a nongut autoimmune disorder.
SFB are Gram positive, spore-forming obligate anaerobes that
have not yet been successfully cultured in vitro (Klaasen et al.,
1992). Most closely related to Clostridia, and provisionally desig-
nated Candidatus arthromitus (Snel et al., 1995), they are long
and filamentous, comprised of multiple segments with distinct
septa (Klaasen et al., 1992). SFB-like bacteria have been de-
tected morphologically in the ileum of all vertebrate species
studied to date, including Homo sapiens (Klaasen et al.,
1993a). They colonize the gut of mice at weaning (Garland
et al., 1982), when they adhere tightly to epithelial cells of the
ileum (Klaasen et al., 1992). SFB have been known for some
time to interact with the immune system, promoting the develop-
ment of robust LP lymphocyte populations, the secretion of IgA,
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Figure 5. Linking Gut and Spleen IL-17 Cells
(A) SI-LP lymphocytes were isolated from SPF or GF K/BxN mice. Cells were stained, analyzed by flow cytometry, and gated as indicated. Expression of IL-17
versus CCR6 is plotted. The values indicate percentages of IL-17+CCR6+ cells in CD3+CD4+B220 cells. Data are representative of three independent
experiments.
(B) SI-LP lymphocytes (top) and splenocytes (middle) were isolated from SPF mice of the indicated ages, stained, and analyzed by flow cytometry, gated as
indicated. Plots displayed IL-17 versus CCR6 expression. Values indicate percent of IL-17+CCR6+ cells in total CD4+ T cells (CD3+CD4+B220). Data are
representative of two independent experiments. Bottom: Measurement of ankle thickening for the same mice. Each circle represents one animal from two
independent experiments.
(C) Splenocytes from SPF BxN or K/BxN mice were stained and analyzed by flow cytometry, gated as indicated. Plots depict IL-17 versus a4b7 staining. Values
indicate percent of IL-17+a4b7+ or IL-17+a4b7 cells in total CD4+ T cells (CD3+CD4+B220). Data are representative of two independent experiments.
Immunity
The Gut Microbe SFB Can Trigger Arthritisand the recruitment of intraepithelial lymphocytes (Klaasen et al.,
1993b; Talham et al., 1999; Umesaki et al., 1995). Not surpris-
ingly, then, this bacterial species has been reported to impact
on intestinal immune responsiveness (Stepankova et al., 2007;
Ivanov et al., 2009).
How does SFB promote the development of joint inflammation
in K/BxN mice? K/BxN arthritis relies strongly on IL-17, and the
appearance of IL-17-producing Th cells in both the intestinal
LP and spleen depends critically on gut microbes, in particular
SFB (shown here; Atarashi et al., 2008; Ivanov et al., 2008,
2009; Salzman et al., 2010; Gaboriau-Routhiau et al., 2009;
Niess et al., 2008). We do not rule out the possibility that other
commensals can promote, or can synergize with, SFB in
promoting arthritis in this model, but other species, including
members of the SFB-related Clostridiaceae family, were not
able to induce the accumulation of SI-LP Th17 cells in a previous
set of studies (Ivanov et al., 2009).
An early step in K/BxN disease induction is likely to be activa-
tion of APCs residing in the intestinal LP, as indicated by the fact
that gut microbes can have an indirect adjuvant effect in path-
ogen infections (e.g., Benson et al., 2009). It was recently shown
that ATP produced by gut bacteria drives a unique population
of CD70hiCD11clo colonic LP APCs to produce IL-6, IL-23, and
other factors that favor the differentiation of the Th17 cell subset,and that ex vivo coculture of these APCs with naive CD4+ T
lymphocytes induces the appearance of Th17 cells (Atarashi
et al., 2008). However, SFB does not appear to operate via ATP
in the SI-LP, instead upregulating the production of acute-phase
isoforms of SAA in the ileum, which can act on DCs from the
SI-LP to induce cocultured naive CD4+ T cells to differentiate
into Th17 cells (Ivanov et al., 2009).
The activation of APCs in the SI-LP should be sufficient to drive
an anti-GPI Th17 cell response in the vicinity and, indeed, 6- to
8-week-old SPF K/BxN mice showed a near doubling of SI-LP
Th17 cells compared with SPF BxN animals (data not shown).
Given that GPI is expressed in all cell types and circulates in
low amounts in the blood and that this is a TCR-transgenic
system with a high frequency of self-reactive T cells, there is
no need to invoke more complicated scenarios entailing molec-
ular mimicry (Harkiolaki et al., 2009) in this context, i.e., the initial
activation of GPI-reactive T cells does not depend on cross-
reactivity to a gut-microbe antigen.
Once generated, GPI-reactive SI-LP Th17 cells are competent
to exit the gut and recirculate (Sigmundsdottir and Butcher,
2008). Gut APCs, in particular the CD103+ subset of intestinal
LP DCs, produce elevated amounts of retinoic acid, which
induces associated T cells to express the gut-homing receptor,
the a4b7 integrin. These ‘‘gut-imprinted’’ T cells recirculateImmunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc. 821
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Figure 6. Effects of Various Antibiotics
(A) Representative dot plots examining expression of IL-17 and CCR6 by SI-LP lymphocytes in untreated or the indicated antibiotic-treated SPF K/BxN mice,
treated from birth to 5 weeks of age. Values refer to percent of the gated population in total CD4+ T cells. Representative of two independent experiments.
(B) SPF K/BxN mice were treated with metronidazole (1 g/l), neomycin (1 g/l), vancomycin (0.5 g/l), or ampicillin (1 g/l) in the drinking water from birth. At 5 weeks of
age, SI-LP lymphocytes (left) and splenocytes (right) were isolated, stained, and analyzed by flow cytometry. Plotted are the percent of IL-17+ cells of total CD4+
T cells. Mean + SEM (data were a combination of two independent experiments with mice treated with metronidazole [n = 4], neomycin [n = 4], vacomycin [n = 4],
ampicillin [n = 4], or nothing [n = 8]). Asterisks indicate statistical significance using the Student’s t test, **p < 0.005.
(C) Representative dot plots examining expression of a4b7 on IL-17-producing splenocytes in untreated (left) or vancomycin-treated (right) SPF K/BxN mice,
treated from birth to 5 weeks of age. Values refer to percent of the gated population in total CD4+ T cells. Representative of two independent experiments.
(D) K/BxN mice were untreated or were treated with metronidazole (1 g/l), neomycin (1 g/l), ampicillin (1 g/L), or vancomycin (0.5 g/l) in the drinking water
from birth. Ankle thickening was followed from day 27. Mean ± SEM (none group, n = 5; all other antibiotics-treated groups, n = 4). Asterisks indicate statistical
significance of area under curve with the Student’s t test, **p < 0.005. Representative of two independent experiments.
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The Gut Microbe SFB Can Trigger Arthritisthrough the intestinal lymphatics, enter the bloodstream, and
preferentially home back to the LP. In the K/BxN system, a pop-
ulation of a4b7-expressing Th17 cells was retained in the spleen,
where they are positioned to provide help for the characteristi-
cally massive GPI autoAb response. The alternative explanation
(that CD103+ DCs migrate from the gut to the spleen and induce
a4b7+ Th17 cells) is less likely, given reports that gut DCs gener-
ally do not migrate beyond the mesenteric lymph nodes
(Macpherson and Uhr, 2004; Voedisch et al., 2009). The IL-17
produced by Th17 cells was required for effective GC formation
in K/BxN spleens, which was a direct effect of this cytokine on B
cells. Although IL-17 is not generally thought of as a ‘‘helper’’
cytokine for B cells, our data are reminiscent of findings on
the BXD2 model that argued that this cytokine can act on
B cells by suppressing their chemotactic response to CXCL12
(Hsu et al., 2008).
The generation of high titers of GPI autoAbs is a pivotal event
in the K/BxN model (Korganow et al., 1999). They combine with822 Immunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc.circulating GPI to form immune complexes, which are deposited
along the noncellular joint surface where the cartilage meets
the articular cavity (Matsumoto et al., 2002). Because of the
dearth of inhibitors at this site, the alternative pathway of
complement is activated, leading to the recruitment and activa-
tion of inflammatory leukocytes. As has been discussed at length
(Matsumoto et al., 2002; Binstadt et al., 2006), the joint speci-
ficity of the autoinflammation in the K/BxN model does not result
from joint-specific T or B cell responses, but rather from partic-
ularities of joint structure and physiology. Indeed, it is difficult
to find any anti-GPI T and B cells in the joint itself (Kouskoff
et al., 1996). Although the low titer of anti-GPI in the absence
of SFB suffices in and of itself to explain the dampening of
arthritis observed in GF-housed mice (Matsumoto et al., 1999),
it remains possible that commensal microbes also impact on
downstream disease processes. Indeed, a positive influence of
Th17 cells on the K/BxN serum-transfer system was recently
described (Jacobs et al., 2009).
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Figure 7. Triggering of Arthritis in SFB-Colonized GF K/BxN Mice
(A) Experimental scheme. Mice were shipped from the GF Taconic facility to
the SPF NYU facility on day 21 after birth and arrived the next day. After a
3-day rest, they were gavaged with SFB mono-feces or control GF feces
(the rare animal with already swollen ankles was not used). Ankle thickening
was measured every day from day 27 to day 33.
(B) Measurement of ankle thickness beginning on day 27. n = 9 for SFB-treated
and n = 5 for controls from four independent experiments. Asterisks indicate
statistical significance via the Student’s t test, *p < 0.05.
(C) Quantitative PCR analysis of SFB and total bacterial (EUB) 16S rRNA genes in
mouse feces. GF K/BxN mice were gavaged either with their own feces (C) or with
feces fromSFBmono-colonizedmice (SFB).GenomicDNAwas isolated fromfecal
pellets on day 6 after gavage. Data combined from two separate experiments.
Immunity
The Gut Microbe SFB Can Trigger ArthritisThe influence of microbial commensals on arthritis develop-
ment in other mouse models has been variable, covering the
range from inhibition to little effect to augmentation (Bjo¨rk
et al., 1994; Chervonsky, 2010). However, the significance of
these studies is difficult to assess because, in general, they relied
on the administration of bacteria or bacterial products (often
Complete Freunds’ Adjuvant) for the induction of disease. Our
findings are conceptually different from the observation that
fungal infection, probably through the lungs and/or skin of
conventionally (compared with SPF-) housed mice, augments
arthritis development in the skg model (Yoshitomi et al., 2005).
Because of the relatively high rate of discordance of human
rheumatoid arthritis (RA) in monozygotic twins, the role of
microbes in this disorder has been of great interest, although
the conclusions have often been contentious (Edwards, 2008).
Most of the attention has been devoted to disease correlations
with infectious microorganisms, resulting in claims of associa-
tion with a number of them, including Mycobacterium tubercu-
losis, Proteus mirabilis, Escherichia coli, Epstein-Barr virus,
retroviruses, etc. However, none of the associations has
emerged as dominating, and mechanistic insights are lacking.
Only of late has some of the focus shifted to the potential influ-
ence of microbial commensals. Vaahtovuo et al. reported
differences in the intestinal microbiota of patients with early
(<6 month duration) RA vis-a`-vis controls with fibromyalgia, as
assessed from the 16S rRNA composition of fecal samples
(Vaahtovuo et al., 2008), but it is difficult to distinguish cause
from effect in such a study. Clearly, this is an area that merits
further exploration, which will probably need to partner with
studies on animal models to establish causality, permit mecha-
nistic dissection, and allow preclinical evaluation of suggested
therapeutic strategies. Indeed, antibiotics such as sulfasalazine
and minocyline have been known for some time to have benefi-
cial effects on RA progression, but underlying mechanisms
remain the subject of substantial controversy (Stone et al., 2003).
More generally, commensal microbes can have a variable
influence on different spontaneously developing autoimmune
diseases (Chervonsky, 2010). For example, introduction of
Aire/ mice into a GF facility had no significant impact on the
severity or scope of the multiorgan autoinflammation that
appears under SPF conditions (Gray et al., 2007). And it is well
known that the penetrance of type-1 diabetes in the NOD mouse
strain increases with cleaner housing conditions, rising to 100%
in GF facilities (Pozzilli et al., 1993). It is tempting to speculate
that these divergent effects might, at least in part, reflect the
various diseases’ differential dependence on particular Th
subsets. In this regard, it may be relevant that for neither of these(D) SI-LP lymphocytes were isolated from control or SFB-inoculated K/BxN
mice. Cells were stained and analyzed by flow cytometry. Expression of
IL-17 versus IFN-g is plotted. Values refer to percent of the gated population
in total CD4+TCRb+ cells.
(E) Splenocytes were isolated from control or SFB-inoculated K/BxN mice and
were stained and analyzed by flow cytometry, gated as indicated. Plots depict
IL-17 versus a4b7 staining. Values indicate percent of IL-17+a4b7+ or
IL-17+a4b7 cells in total CD4+ T cells (B220 CD3+CD4+). Data are represen-
tative of two independent experiments.
(F) Sera were collected from control or SFB-inoculated K/BxN animals at the
end of the experiment depicted in (A). The bar indicates the mean. Asterisks
indicate statistical significance via the Student’s t test, *p < 0.05.
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Immunity
The Gut Microbe SFB Can Trigger Arthritisdiseases has there emerged definitive evidence of a critical role
for Th17 cells (Devoss et al., 2008; Martin-Orozco et al., 2009;
Bending et al., 2009; Emamaullee et al., 2009).EXPERIMENTAL PROCEDURES
Mice
K/BxN mice were generated by crossing KRN TCR transgenic mice on the B6
background (KRN/B6) (Kouskoff et al., 1996) with NOD mice in an SPF facility
at the Harvard School of Public Health. Pups from KRN/B6 and NOD-back-
ground lines were rederived by cesarean section into the GF facility at Taconic
Farms (Hudson, NY). Individuals from the two lines were crossed to generate
K/BxN experimental animals. All GF mice were given sterilized food (NIH 31M)
and water and were tested weekly to establish that they were free of aerobic
and anaerobic bacteria, parasites, and fungi. Sentinel mice were also tested
routinely and found to be negative for viral serologies. A complete list of
excluded organisms is available on request. Mice were shipped in GF
containers by Taconic to Boston or New York for measuring arthritis and
obtaining experimental organs for analysis. Rag1/ mice on the B6xNOD
background (BxNRag/) were obtained from our colony at the Jackson Labo-
ratory. Il17ra/ mice (Ye et al., 2001) were obtained from Amgen Washington
and were bred with B6g7 mice at our animal facility at the Harvard School of
Public Health. ifng-deficient mice on the B6 genetic background were
purchased from the Jackson Laboratory (Dalton et al., 1993), and appropriate
crosses were performed to yield K/BxN mice homozygous or heterozygous for
the Ifng null mutation.
IL-17 was neutralized by treatment with a mAb recognizing it (MAB421, R&D
Systems). Control Abs were purified polyclonal rat IgG (Jackson Immunore-
search).
For antibiotic treatment, 1 g/L of ampicillin sodium salt (Sigma), 1 g/L of
metronidazole (Acros Organics), 0.5 g/L vancomycin hydrochloride (Acros
Organics), or 1 g/l of neomycin (Fisher BioReagents) were used as previously
described (Atarashi et al., 2008). Antibiotics were added to the drinking water
on a weekly basis. Sweetener (Equal) was added to the water (2.5 g/L). For the
treatment of neonates, antibiotic-supplemented water was provided to
lactating mothers.
Ankle thickness was measured with a caliper (J15 Blet micrometer) as
described previously (Wu et al., 2007). Mice were maintained at the Harvard
Medical School facility unless otherwise mentioned. All experiments were
done with protocols approved by Harvard Medical School’s Institutional
Animal Care and Use Committee.ELISAs
Anti-GPI Ab titers were measured as described (Matsumoto et al., 1999). In
brief, ELISA plates were coated with recombinant mouse GPI at 5 mg/ml,
and diluted mouse sera was added. Subsequently, alkaline-phosphatase
(AP)-conjugated anti-mouse IgG, IgG1, or IgG2a followed by AP-conjugated
streptavidin were applied. After substrate addition, titers were quantified as
optical density (OD) values via an ELISA reader.Flow Cytometry
Cells were collected for flow cytometry by filtering crushed spleen or thymus
through a 40 mm nylon membrane. For surface staining, fluorophore-labeled
mAbs specific for CD4, CD8, CD3, CD25, CD44, Fas, CD19, IgM, IgD,
CD21, CD23, CXCR5, PD-1, CD45.1, or CD45.2 were obtained from BD
PharMingen. Anti-a4b7 and anti-CCR6 were from Biolegend. PNA-R was
from Vector Laboratories. For intracellular cytokine staining, immediately after
isolation, the cells were incubated for 4 hr with 50 ng/ml phorbol 12-myristate
13-acetate (Sigma), 1 mM ionomycin (Sigma), and BD GolgiPlug (1:1000
dilution) at 37C. Intracellular cytokine staining was performed with Cytofix/
Cytoperm (BD PharMingen) per the manufacturer’s instructions. Abs recog-
nizing IL-17 and IFN-g were obtained from Biolegend and BD PharMingen,
respectively. Foxp3 staining, Foxp3 Staining Buffer Set was obtained from
eBioscience, and intracellular staining was performed according to the
manufacturer’s instructions. Cells were run on an LSRII (BD Biosciences),
and analysis was performed with FloJo (TreeStar) software.824 Immunity 32, 815–827, June 25, 2010 ª2010 Elsevier Inc.ELISPOT Assay
ELISPOT assays were performed with Multiscreen IP Plates (Millipore). The
plates were prewet with 15 ml of 35% ethanol (v/v in Milli-Q water) for 1 min,
rinsed with 150 ml sterile phosphate-buffered saline (PBS) three times, coated
with 100 ml (10 mg/ml) recombinant GPI (Matsumoto et al., 2002) in sterile PBS,
and incubated overnight at 4C. The next day, plates were washed with Milli-Q
water and blocked with 150 ml per well of tissue-culture medium (RPMI-1640,
10% fetal bovine serum, 1% nonessential amino acids, penicillin, strepto-
mycin, glutamine) for 2 hr at 37C. B cells from BxN or K/BxN mice were
positively isolated with directly conjugated MACS beads (Miltenyi Biotec)
according to the manufacturer’s instructions. Cells were resupended at 2.5 3
106 cells/ml in medium, and 100 ml of cell suspension was added into the wells.
Cells were serially diluted and incubated for 6 hr at 37C. After washing, alkaline
phosphatase-conjugated anti-mouse total IgG was applied, and the plates
were incubated for 2 hr at 37C. Plates were then washed, and 1 step NBT/
BCIP substrate (Pierce) was added. Spots were developed during 5 min of
incubation at room temperature. The plates were rinsed with water, dried
overnight in the dark, and analyzed with the CTL-ImmunoSpot UV Analyzer.
T Cell Proliferation and T Cell Suppression Assays
For T cell proliferation assays, total splenocytes (2 3 105) in tissue-culture
medium were added to 96-well plates. GPI peptide (GPI282-294) was added to
the culture at various concentrations as indicated in the relevant figure. After
2 days of culture, 1 mCi of 3H-thymidine was added to each well, the plates
were incubated overnight, and cells were harvested and the radioactivity deter-
mined by a beta counter. For T cell suppression assays, responder T cells
(CD4+CD25) were sorted from spleens of SPF K/BxN mice and Treg cells
(CD4+CD25+) were sorted from spleens of either GF or SPF K/BxN mice.
Responder T cells were stimulated with anti-CD3/CD28 beads (Dynabeads,
Invitrogen) and cultured in complete medium at a density of 2.5 3 104–5.0 3
104 cells/well, either alone or with various concentrations of Treg cells for
3 days. 3H-thymidine incorporation was examined as described above.
Gene-Expression Analyses
RNA was prepared as described (Hill et al., 2008). For microarray analysis,
RNA was labeled and hybridized to GeneChip Mouse Genome 430 2.0 arrays
according to the Affymetrix protocols. GF or SPF splenic CD3+CD4+ T cells
from BxN or K/BxN mice were isolated via MoFlo sorting (DakoCytomation).
Data were analyzed with Multiplot software. The Th1, Th2, and Th17 cell signa-
tures were derived from the data of Dong and collaborators (Nurieva et al.,
2008), each signature generated with 2 as an arbitrary FC cut-off over the
expression value of the other two cell types.
RNA was isolated from splenocytes via Trizol (6756) and was reverse
transcribed with oligo dT priming and Superscript polymerase (Invitrogen).
Quantitative RT-PCR was performed on an Mx3000p instrument (Stratagene),
with gene-specific fluorogenic assays (TaqMan, Applied Biosystems).
Forward primers (FPs) and reverse primers (RPs) were from MWG Biotech,
and probes for IL-4 and IFN-g were ordered from Applied Biosystems. IL-4
(FP, TCCTCACAGCAACGAAGAACAC; RP, CAAGCATGGAGTTTTCCCATG;
probe, TGTAGGGCTTCCAAGGTGCTTCGCATATT), IFN-g (FP, CAGCAACAG
CAAGGCGAAA; RP, CTGGACCTGTGGGTTGTTGAC; probe, TCAAACTTGG
CAATACTCATGAATGCATCCT). For IL-17A, a 10 ml final reaction mix contain-
ing TaqMan Universal PCR Master Mix (Applied Biosystems) and IL-17A
TaqMan Gene Expression Assays (Mm00439619_m1) were used. Cytokine
transcripts in spleens were quantified by RT-PCR with hypoxanthine guanine
phosphoribosyl transferase mRNA as an internal standard.
Cell Transfers
B cells were positively purified on B220-conjugated MACS beads from
B6g7.Il17ra/ mice or WT B6g7 littermate controls. B cells (13 107) from either
WT or Il17ra/ mice were combined with splenocytes (1.23 107) from arthritic
K/BxN mice and were transferred into lightly irradiated (450R) BxN.Rag1/
recipients. Recipient mouse splenocytes were isolated after 2 weeks for flow
cytometric analyses of B cell reconstitution.
SI-LP Cell Isolation and Analysis
SI-LP were isolated as described, with some modification (Ivanov et al., 2006;
Atarashi et al., 2008). In brief, the SI was taken, residual mesenteric fat tissue
Immunity
The Gut Microbe SFB Can Trigger Arthritiswas removed, Peyer’s patches were carefully excised, and the intestine was
opened longitudinally. It was then thoroughly washed in ice-cold PBS and
cut into 1 cm pieces, which were incubated twice in 25 ml of 5 mM ethylene-
diaminetetraacetic acid (EDTA) and 0.145 mg/ml DL-Dithiothreitol (DTT) in
Dulbecco’s Modified Eagle Medium (DMEM) for 40 min at 37C at a rotation
speed of 200 rpm. After incubation, the epithelial cell layer, containing the
intraepithelial lymphocytes, was removed by intensive vortexing and passing
through a 100 mm cell strainer. After the second EDTA incubation, the bits
were washed in PBS, cut into 1 mm2 pieces with scissors, and placed in
15 ml digestion solution containing 1 mg/ml each of Collagenase D (Roche)
and 0.15 mg/ml DNase I (Sigma), and 200 ng/ml liberase Cl (Roche). Digestion
was performed by incubating the pieces at 37C for 20 min with rotation. After
the initial 20 min, the solution was vortexed intensely and passed through a
100 mm cell strainer. The supernatants were passed through a 40 mm cell
strainer and the cells were resuspended in 10% DMEM medium for stimulation.
Microbiota Reconstitution
For inoculation of GF mice with SFB, fecal pellets were collected from SFB-
monocolonized mice with sterilized test tubes in the vinyl-isolator and were
preserved frozen under dry ice until immediately before oral administration.
Colonizations were performed by oral gavage with 300–400 ml of suspension
obtained by homogenizing the fecal pellets in water. Control mice were gav-
aged with homogenates prepared from their own feces. Mice were maintained
in the Skirball Institute Animal Facility. All experiments were done in accor-
dance with a protocol approved by the Institutional Animal Care and Use
Committee of the New York University School of Medicine.
16S rRNA Gene Quantitative PCR Analysis
Bacterial genomic DNA was extracted from fresh or frozen fecal samples
(within an experiment the samples were treated identically) by phenol-chloro-
form extraction as previously described (Ivanov et al., 2009).
Statistical Analysis
Asterisks indicate statistical significance. Differences were considered signif-
icant at p < 0.05 by the Student’s t test (two-tailed, unpaired). Where indicated,
p values from chi-square (c2) tests were used instead. The area under the
curve (AUC) was calculated for each animal in an experimental set followed
by a Student’s t test between groups (Prism 5; Graph-Pad Software, San
Diego, CA).
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